Stocks and Investing Stocks and Investing
Mon, May 9, 2022
Fri, May 6, 2022

Joseph Stringer Maintained (VIR) at Strong Buy with Decreased Target to $35 on, May 6th, 2022


Published on 2024-10-27 20:55:09 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $45 to $35 on, May 6th, 2022.

Joseph has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022


This is the rating of the analyst that currently disagrees with Joseph


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $200 on, Wednesday, March 30th, 2022
Contributing Sources